ASHLEIGH GEHRET: Open Payments
NPI 1265993307 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 95 payments from 16 companies in 2025. Trend: 2023 $2,176 · 2024 $2,077 · 2025 $1,805
Food & beverage: $1,775Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $526 |
| Novo Nordisk Inc | 15 | $302 |
| PFIZER INC. | 11 | $210 |
| Abbott Laboratories | 10 | $171 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $57 |
Products named: UBRELVY, Ozempic, FREESTYLE LIBRE 3, QULIPTA, NURTEC ODT, ELIQUIS, LEQVIO, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
